WCG Wealth Advisors’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.51M Buy
37,233
+4,948
+15% +$330K 0.06% 276
2026
Q1
$2.03M Buy
32,285
+1,551
+5% +$108K 0.06% 270
2025
Q4
$2.04M Buy
+30,734
New +$1.99M 0.06% 259
2024
Q1
– Sell
-19,107
Closed -$2.37M – 271
2023
Q4
$2.37M Sell
19,107
-154
-0.8% -$15.7K 0.17% 118
2023
Q3
$1.8M Buy
+19,261
New +$2.17M 0.13% 144

Other funds holding DXCM

WCG Wealth Advisors's DXCM Position: Q2 2026 in Review

WCG Wealth Advisors increased its DexCom (DXCM) stake by 15% in Q2 2026, buying an estimated $330K and bringing the position to 37,233 shares worth $2.51M. The position accounts for 0.06% of the portfolio, ranked #276.

WCG Wealth Advisors first reported a position in DXCM in Q3 2023 and has held it in 5 quarters since. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • WCG Wealth Advisors held 37,233 shares of DexCom worth $2.51M as of Q2 2026.
  • WCG Wealth Advisors bought 4,948 DexCom shares in Q2 2026, an estimated $330K.
  • DexCom made up 0.06% of WCG Wealth Advisors's portfolio in Q2 2026, its #276 holding.
  • WCG Wealth Advisors first reported a position in DexCom in Q3 2023 and has held it in 5 quarters since.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on WCG Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.